The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Impaired early B cell tolerance in patients with rheumatoid arthritis
Open accessAbstract
Autoantibody production is a characteristic of most autoimmune diseases including rheumatoid arthritis (RA). The role of these autoantibodies in the pathogenesis of RA remains elusive, but they appear in the serum many years before the onset of clinical disease suggesting an early break in B cell tolerance. The stage of B cell development at which B cell tolerance is broken in RA remains unknown. We previously established in healthy donors that most polyreactive developing B cells are silenced in the bone marrow, and additional autoreactive B cells are removed in the periphery. B cell tolerance in untreated active RA patients was analyzed by testing the specificity of recombinant antibodies cloned from single B cells. We find that autoreactive B cells fail to be removed in all six RA patients and represent 35–52% of the mature naive B cell compartment compared with 20% in healthy donors. In some patients, RA B cells express an increased proportion of polyreactive antibodies that can recognize immunoglobulins and cyclic citrullinated peptides, suggesting early defects in central B cell tolerance. Thus, RA patients exhibit defective B cell tolerance checkpoints that may favor the development of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Self-citationRantapää‐Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U., & van Venrooij, W. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,953
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., et al. (1988) · Nature · doi:10.1038/334676a0 · Cited by 1,565
Begovich, A. B., Carlton, V. E. H., Honigberg, L. A., Schrodi, S. J., Chokkalingam, A. P., Alexander, H. C., Ardlie, K. G., Huang, Q., Smith, A. M., Spoerke, J. M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422827 · Cited by 1,502
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
Nemazee, D. A., & Bürki, K. (1989) · Nature · doi:10.1038/337562a0 · Cited by 1,016
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay, D., Saunders, T., Camper, S., & Weigert, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.999 · Cited by 920
Organ-Specific Disease Provoked by Systemic Autoimmunity
Kouskoff, V., Korganow, A.-S., Duchatelle, V., Degott, C., Benoist, C., & Mathis, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81989-3 · Cited by 892
Sakaguchi, N., Takahashi, T., Hata, H., Nomura, T., Tagami, T., Yamazaki, S., Sakihama, T., Matsutani, T., Negishi, I., Nakatsuru, S., et al. (2003) · Nature · doi:10.1038/nature02119 · Cited by 878
Receptor editing in self-reactive bone marrow B cells.
Tiegs, S. L., Russell, D. M., & Nemazee, D. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1009 · Cited by 766
Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., & Brink, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.010 · Cited by 746
Defective B cell tolerance checkpoints in systemic lupus erythematosus
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., & Nussenzweig, M. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042251 · Cited by 717
Self-citationHill, J. A., Southwood, S., Sette, A., Jevnikar, A. M., Bell, D. A., & Cairns, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.538 · Cited by 713
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214121 · Cited by 712
The role of clonal selection and somatic mutation in autoimmunity
Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L., & Weigert, M. G. (1987) · Nature · doi:10.1038/328805a0 · Cited by 701
Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE
Kyogoku, C., Ortmann, W. A., Lee, A., Selby, S., Carlton, V. E. H., Chang, M., Ramos, P., Baechler, E. C., Batliwalla, F. M., Novitzke, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423790 · Cited by 672
Identification and characterization of circulating human transitional B cells
Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G., & Lipsky, P. E. (2005) · Blood · doi:10.1182/blood-2004-11-4284 · Cited by 604
Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF
Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H.-B., & Cyster, J. G. (2004) · Immunity · doi:10.1016/s1074-7613(04)00079-2 · Cited by 577
Cyster, J. G., Hartley, S. B., & Goodnow, C. C. (1994) · Nature · doi:10.1038/371389a0 · Cited by 535
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Most peripheral B cells in mice are ligand selected.
Gu, H., Tarlinton, D., Müller, W., Rajewsky, K., & Förster, I. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1357 · Cited by 417
B lymphocytes may escape tolerance by revising their antigen receptors.
Radic, M. Z., Erikson, J., Litwin, S., & Weigert, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1165 · Cited by 407
Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy
Silverman, G. J., & Weisman, S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10947 · Cited by 367
Peripheral deletion of self-reactive B cells
Russell, D. M., Dembić, Z., Morahan, G., Miller, J. F. A. P., BÜrki, K., & Nemazee, D. (1991) · Nature · doi:10.1038/354308a0 · Cited by 352
Sebbag, M., Simon, M., Vincent, C., Masson-Bessière, C., Girbal, E., Durieux, J. J., & Serre, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117969 · Cited by 344
Cyster, J. G., & Goodnow, C. C. (1995) · Immunity · doi:10.1016/1074-7613(95)90059-4 · Cited by 273
Ectopic Germinal Center Formation in Rheumatoid Synovitis
WEYAND, C. M., & GORONZY, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06042.x · Cited by 241
Liossis, S. N., Kovacs, B., Dennis, G., Kammer, G. M., & Tsokos, G. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119073 · Cited by 225
Kurosaki, T., & Tsukada, S. (2000) · Immunity · doi:10.1016/s1074-7613(00)80153-3 · Cited by 223
Autoantibodies as predictors of disease
Leslie, D., Lipsky, P., & Notkins, A. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14452 · Cited by 215
Light chain replacement: a new model for antibody gene rearrangement.
Prak, E. L., & Weigert, M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.541 · Cited by 191
BCR Ligation Induces Receptor Editing in IgM+IgD− Bone Marrow B Cells In Vitro
Hertz, M., & Nemazee, D. (1997) · Immunity · doi:10.1016/s1074-7613(00)80286-1 · Cited by 179
de Weers, M., Brouns, G. S., Hinshelwood, S., Kinnon, C., Schuurman, R. K., Hendriks, R. W., & Borst, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51014-6 · Cited by 178
Ghia, P., ten Boekel, E., Sanz, E., de la Hera, A., Rolink, A., & Melchers, F. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2217 · Cited by 171
A B-cell receptor-specific selection step governs immature to mature B cell differentiation
Levine, M. H., Haberman, A. M., Sant’Angelo, D. B., Hannum, L. G., Cancro, M. P., Janeway, C. A., & Shlomchik, M. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050552997 · Cited by 154
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Self-citationSurrogate Light Chain Expressing Human Peripheral B Cells Produce Self-reactive Antibodies
Meffre, E., Schaefer, A., Wardemann, H., Wilson, P. C., Davis, R. E., & Nussenzweig, M. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031550 · Cited by 151
Self-citationBruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
Ng, Y.-S., Wardemann, H., Chelnis, J. G., Cunningham‐Rundles, C., & Meffre, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040920 · Cited by 147
Self-citationMelamed, D., & Nemazee, D. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9267 · Cited by 143
Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus.
Dörner, T., Foster, S. J., Farner, N. L., & Lipsky, P. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3113 · Cited by 109
Victor, K. D., Randen, I., Thompson, K. M., Førre, Ø., Natvig, J. B., Fu, S. M., & Capra, J. D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115174 · Cited by 105
Bridges, S. L., Lee, S. K., Johnson, M. L., Lavelle, J. C., Fowler, P. G., Koopman, W. J., & Schroeder, H. W. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118129 · Cited by 71
Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells
Wasserman, R., Li, Y. S., & Hardy, R. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1133 · Cited by 69
Tze, L. E., Hippen, K. L., & Behrens, T. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.678 · Cited by 25
Cited by
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Self-citationFollicular B helper T cells in antibody responses and autoimmunity
Vinuesa, C. G., Tangye, S. G., Moser, B., & Mackay, C. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1714 · Cited by 624
Mechanisms of central tolerance for B cells
Nemazee, D. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.19 · Cited by 539
Yap, H.-Y., Tee, S. Z.-Y., Wong, M. M.-T., Chow, S.-K., Peh, S.-C., & Teow, S.-Y. (2018) · Cells · doi:10.3390/cells7100161 · Cited by 486
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
Metadata
- Authors
- Samuels, J., Ng, Y.-S., Coupillaud, C., Paget, D., & Meffre, E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-05-16
- Volume
- 201
- Issue
- 10
- Pages
- 1659-1667
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2141301927
- Cited by
- 328
- References
- 47
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.